These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3196509)

  • 21. Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes.
    Grooteman MP; Nubé MJ; Daha MR; Van Limbeek J; van Deuren M; Schoorl M; Bet PM; Van Houte AJ
    J Am Soc Nephrol; 1997 Nov; 8(11):1745-54. PubMed ID: 9355078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrapure dialysate: facts and myths.
    Bommer J; Jaber BL
    Semin Dial; 2006; 19(2):115-9. PubMed ID: 16551288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the DialGuard device for endotoxin removal in hemodialysis.
    Szathmary S; Hegyi E; Amoureux MC; Rajapakse N; Chicorka L; Szalai G; Reszegi K; Derbyshire Z; Paluh J; Dodson B; Grandics P
    Blood Purif; 2004; 22(5):409-15. PubMed ID: 15316195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence for endotoxin transfer across high flux polysulfone membranes.
    Bommer J; Becker KP; Urbaschek R; Ritz E; Urbaschek B
    Clin Nephrol; 1987 Jun; 27(6):278-82. PubMed ID: 3608251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hollow-fiber dialyzers and their pyrogenicity testing by Limulus amebocyte lysate.
    Henne W; Schulze H; Pelger M; Tretzel J; von Sengbusch G
    Artif Organs; 1984 Aug; 8(3):299-305. PubMed ID: 6477197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High sensitivity pyrogen testing in water and dialysis solutions.
    Daneshian M; Wendel A; Hartung T; von Aulock S
    J Immunol Methods; 2008 Jul; 336(1):64-70. PubMed ID: 18474369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endotoxemia after high cutoff hemodialysis for treatment of patient with multiple myeloma can be prevented by using ultrapure dialysate: a case report.
    Gong D; Ji D; Zhang K; Huang X; Huang G; Xu B; Liu Z
    Hemodial Int; 2013 Oct; 17(4):618-23. PubMed ID: 23113894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrogen retention by the Asahi APS-650 polysulfone dialyzer during in vitro dialysis with whole human donor blood.
    Linnenweber S; Lonnemann G
    ASAIO J; 2000; 46(4):444-7. PubMed ID: 10926143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dialysate purity: a must.
    Ramírez R; Carracedo J; Martín-Malo A; Rodríguez M; Aljama P
    Contrib Nephrol; 2002; (137):325-31. PubMed ID: 12101973
    [No Abstract]   [Full Text] [Related]  

  • 30. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis.
    Schouten WE; Grooteman MP; van Houte AJ; Schoorl M; van Limbeek J; Nubé MJ
    Nephrol Dial Transplant; 2000 Mar; 15(3):379-84. PubMed ID: 10692524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In search of sterile, endotoxin-free dialysate.
    Gault MH; Duffett AL; Murphy JF; Purchase LH
    ASAIO J; 1992; 38(3):M431-5. PubMed ID: 1457896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis.
    Tielemans C; Husson C; Schurmans T; Gastaldello K; Madhoun P; Delville JP; Marchant A; Goldman M; Vanherweghem JL
    Kidney Int; 1996 Jan; 49(1):236-43. PubMed ID: 8770974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.
    Lonnemann G; Koch KM; Shaldon S; Dinarello CA
    J Lab Clin Med; 1988 Jul; 112(1):76-86. PubMed ID: 3260615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriological contamination of dialyzers. Clinical, bacteriological and scanning electron-microscopic evaluation of different dialysate mixing systems.
    Jans H; Bretlau P; Nielsen B
    Nephron; 1978; 20(1):10-7. PubMed ID: 413062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The level of endotoxins in hemodialysis water and dialysate].
    Skarupskiene I; Bumblyte IA; Kuzminskis V
    Medicina (Kaunas); 2007; 43 Suppl 1():81-4. PubMed ID: 17551282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contamination of dialysis water and dialysate. A survey of 30 centers.
    Bambauer R; Schauer M; Jung WK; Daum V; Vienken J
    ASAIO J; 1994; 40(4):1012-6. PubMed ID: 7858320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles.
    Latosinska A; Hulko M; Speidel R; Mischak H; Storr M; Krause B
    Artif Organs; 2018 Jan; 42(1):78-87. PubMed ID: 28744941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membranes for endotoxin removal from dialysate: considerations on feasibility of commercial ceramic membranes.
    Bender H; Pfläzel A; Saunders N; Czermak P; Catapano G; Vienken J
    Artif Organs; 2000 Oct; 24(10):826-9. PubMed ID: 11091173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative potency of "environmental" endotoxin as measured by the Limulus amebocyte lysate test and the USP rabbit pyrogen test.
    Pearson FC; Weary ME; Bohon J; Dabbah R
    Prog Clin Biol Res; 1982; 93():65-77. PubMed ID: 7122606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.